JNCE

Jounce Therapeutics, Inc. JNCE

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JNCE HLVX AADI MIRO IMDX CYT OPNT RVLP BLI TRML
6M 109.45 % 23.67 % -4.65 % 78.42 % 22.41 % -1.63 % 92.09 % -96.93 % -40.59 % 209.75 %
YTD 72.48 % 0.48 % -34.71 % 0.00 % 122.75 % 0.00 % 2.03 % -97.55 % -55.39 % 132.46 %
1Y -49.19 % 11.76 % 12.64 % 5.33 % 134.84 % 55.68 % -3.59 % -98.08 % -78.87 % 86.98 %
3Y -65.94 % -87.39 % -86.82 % -77.76 % -8.30 % -82.64 % 115.55 % -99.54 % -98.17 % 226.39 %
5Y -74.83 % -89.05 % -76.30 % -77.76 % -89.74 % -82.64 % 8.68 % -99.60 % -98.17 % -70.47 %
10Y -89.10 % -89.05 % -97.72 % -77.76 % -96.79 % -82.64 % 41 200.00 % -99.65 % -98.17 % -70.47 %
From the beginning -89.10 % -89.05 % -97.72 % -77.76 % -96.79 % -82.64 % -63.55 % -99.65 % -98.17 % -70.47 %

Dividend

Cyteir Therapeutics, Inc.

Tourmaline Bio, Inc.